Search results
Found 1070 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
We studied how COVID affects mental health and brain disorders up to two years after infection – here’s what we found
General Research
22 August 2022
Higher risk of blood clots in COVID-19 outpatients, largely reduced after vaccination
General Research
19 August 2022
Researchers have studied the association between ambulatory COVID-19 and short-term risk of venal thrombosis and the clinical and genetic risk factors predisposing them to developing post–COVID-19 thrombosis.
Increased risk of some neurological and psychiatric disorders remains two years after COVID-19 infection
General Research
18 August 2022
New diagnoses of disorders including psychosis, dementia, seizures and ‘brain fog’ remain commoner two years after COVID-19 than after other respiratory infections, whereas the increased risks of depression and anxiety after COVID-19 are short-lived and there is no overall excess of cases.
Sensory Supermarket event helps businesses make public-facing spaces more inclusive for autistic people
General Research
12 August 2022
Researchers from the Universities of Oxford and Reading – in collaboration with awareness-raising organisation Sensory Spectacle – are hosting an innovative event called Sensory Supermarket as part of the Sensory Street research project.
Genetic mapping of tumours reveals how cancers grow
General Research
11 August 2022
Researchers from the University of Oxford, KTH Royal Institute of Technology, Science for Life Laboratory, and the Karolinska Institutet, Solna, Sweden, have found that individual prostate tumours contain a previously unknown range of genetic variation.
Tackling suicide risk in people with mental disorders
General Research
10 August 2022
Clinical researchers from Oxford University’s Department of Psychiatry and Oxford Health NHS Foundation Trust, together with colleagues from elsewhere, have developed guidance to help clinicians identify and treat patients at risk of suicide.
Environmental impact of 57,000 multi-ingredient processed foods revealed
General Research
9 August 2022
A study estimating the environmental impact of 57,000 food products in the UK and Ireland has been published by an Oxford-led research team in the journal PNAS.
Oxford spinout MiroBio acquired by Gilead Sciences for $405m
General Innovation Research
4 August 2022
The inflammatory diseases company’s rapid ascent and exit underscores the importance of friendships, partnerships and networks in innovation.
Viral role in Alzheimer's Disease discovered
General Research
2 August 2022
Researchers from Oxford’s Institute of Population Ageing, Tufts University and the University of Manchester have discovered that common viruses appear to play a role in some cases of Alzheimer’s disease (AD).
Researchers develop new breath-driven concept set to transform access to hand prosthetics
General Research
29 July 2022
The new air-powered hand provides a lightweight, low-maintenance and easy-to-use body-powered prosthetic option particularly well suited for children and those in low and middle-income countries.
Professor Hugh Watkins wins £30 million research award to cure killer heart diseases
Awards and Appointments General Research
29 July 2022
The British Heart Foundation award aims to help researchers rewrite DNA, in “defining moment” for cardiovascular medicine.
New rabies vaccine candidate demonstrates promising immune response and safety
General Research
28 July 2022
Researchers from the University of Oxford have today reported new findings from a Phase 1 clinical trial studying the immune response and safety of their newly-developed single shot rabies vaccine, ChAdOx2 RabG - with promising results identified.
Gaming does not appear harmful to mental health, unless the gamer can't stop - Oxford study
General Research
27 July 2022
Societies may tremble when a hot new video game is released, but the hours spent playing popular video games do not appear to be damaging players’ mental health, according to the largest-ever survey of nearly 40,000 gamers and their gaming habits, which was conducted over six weeks by a team from Oxford’s Internet Institute. That does not mean, however, that the research did not throw up some concerns – and, the team argues, much more information is needed before tech regulators, can really rest easy.
Genetic study provides evidence that alcohol accelerates biological aging
General Research
27 July 2022
The short-term effects of excessive drinking are well known, but to date it has been less certain whether alcohol also accelerates the aging process.
Gene variant links trigger finger and carpal tunnel syndrome
General Research
22 July 2022
A new Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences study, published in The Lancet Rheumatology, has found a genetic variant that increases the risk of both carpal tunnel syndrome and trigger finger, and opens the door for new therapies that involve blocking the IGF-1 pathway.
Bringing scientists back together
General Research
20 July 2022
Professor Paul Riley, Director of the Institute of Developmental and Regenerative Medicine discusses how better-designed research buildings can help scientists break out of their silos.
More children aged 8-17 trying to lose weight than a decade ago, including children of a healthy weight
General Research
19 July 2022
Over a quarter (26.5%) of children reported trying to lose weight between 2015 and 2016, a 5% increase over 1997 and 1998, finds new research from the University of Oxford.
Oxford vaccine saved most lives in its first year of rollout
Coronavirus COVID-19 General Research
15 July 2022
When the University of Oxford developed a vaccine that was effective against COVID-19, ensuring that it could be rolled out globally and in perpetuity for low- and middle-income countries was of paramount importance.
New study evaluates pharmacological treatment for insomnia
General Research
15 July 2022
Two drugs, eszopiclone and lemborexant – both not currently licenced for the treatment of insomnia in the UK – were shown to perform better than others, both in the acute and long-term treatment of insomnia in adults, according to a new Oxford study exploring the pharmacological management of insomnia.
Early life infection increases sensitivity to pain in newborn babies
General Research
14 July 2022
Researchers from Oxford’s Department of Paediatrics have discovered that infection can increase a baby’s sensitivity to pain, which may last longer than the infection.